ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: PO0857

Resource Utilization and Provision of In-Hospital Dialysis in an Academic Hospital in New Orleans During the COVID-19 Pandemic

Session Information

Category: Coronavirus (COVID-19)

  • 000 Coronavirus (COVID-19)

Authors

  • Ledoux, Jason R., Department of Nephrology, Ochsner Health System, New Orleans, Louisiana, United States
  • Chauvin, Kenneth, Department of Nephrology, Ochsner Health System, New Orleans, Louisiana, United States
  • Mitchell, Vernelle T., Department of Nephrology, Ochsner Health System, New Orleans, Louisiana, United States
  • Velez, Juan Carlos Q., Department of Nephrology, Ochsner Health System, New Orleans, Louisiana, United States

Group or Team Name

  • Ochsner Nephrology
Background

COVID-19 has caused an ominous healthcare toll in the United States. New Orleans rated among the top affected cities. Acute kidney injury (AKI) requiring renal replacement therapy (RRT) affected 16% of COVID-19-related hospitalizations, resulting in an exponential upsurge in resource utilization related to RRT. We report our single center experience providing metrics of overall utilization and workforce expansion.

Methods

We conducted a prospective collection of data of daily census of hospitalized patients with COVID-19 and AKI or ESKD for 7 weeks (3/8-4/30, 2020) quantifying usage of RRT equipment and allocation of personnel. Two independent electronic health record databases were simultaneously used to track the data.

Results

Within 1 month, in-hospital COVID-19 census peaked at 377 patients, with 97 (26%) of them receiving RRT at peak day. Starting from a mean of 65 patients on RRT per day in pre-COVID-19 era, the estimated RRT growth peaked at 49%. Four out of 10 newly purchased Fresenius K2 SLED machines (FKs) were utilized by week 5 (after delivery, assembly and negative culture). Starting from an average 80% usage of baseline capacity (31 of 38 FKs), usage of 42 K2s at peak revealed 35% growth. Four new reverse osmosis devices were obtained (growth: 25 to 29, 16%) by week 5. For CVVHDF, 4 PrismaFlex machines (PFs) were rented and 10 new PrisMax were bought. Starting from an average 33% usage of baseline capacity (2 of 6 FKs), use of 6 PFs at peak meant 400% growth. Up to 30 nurses were trained virtually on RRT. Eight agency nurses and 6 perfusionists were recruited, to increase the operator number from 21 to 35 (67% growth). Five of 21 (24%) RRT nurses were out of work at peak due to COVID19+ status. One attending physician, 1 nurse practitioner and 2 subspecialty residents were added to the inpatient service, increasing the number of providers from 9 to 13 (44% growth).

Conclusion

The pandemic of COVID-19 resulted in substantial increase in in-hospital RRT demand and resource utilization. Our experience may provide other centers a guide to optimize preparedness in the event of facing a “second wave” of COVID-19 in the near future. Delay in implementation has to be accounted for during strategic planning.